Why the study?
Does routine antiemetic prophylaxis improve outcomes and patient satisfaction compared to symptomatic treatment in patients at risk for PONV?
Population
Patients undergoing surgery at risk for postoperative nausea and vomiting (PONV)
Comparison
Routine antiemetic prophylaxis vs Symptomatic treatment or placebo
Design
Editorial
Authors
Loading...
This editorial argues in favor of risk-stratified routine antiemetic prophylaxis for PONV, challenging the view that symptomatic treatment alone is more cost-effective.
Does routine antiemetic prophylaxis improve outcomes and patient satisfaction compared to symptomatic treatment in patients at risk for PONV?
This editorial argues in favor of risk-stratified routine antiemetic prophylaxis for PONV, challenging the view that symptomatic treatment alone is more cost-effective.
White et al. (1999) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: